141
Downloads
11
Episodes
Biotech, TechBio and Life Science investors can seem a mysterious crew to those who encounter them - come behind the curtain and learn about the view from their side of the negotiating table. Tom Froggatt, CEO of Singular, shares his conversations with angel investors, VCs and others who are active in the human health sector, as they discuss the fundraising market, how they assess investments, the mistakes they see and their advice for those heading out to raise money to save the lives of patients. Come and see what it’s like on the other side of the table....
Episodes
Tuesday Oct 01, 2024
Tuesday Oct 01, 2024
This time on The Other Side of the Table, I sit down with Lazar Bojic from Curie Bio, whose work is instrumental in helping biotech founders keep control of their companies while getting the support they need.
Lazar shares Curie’s unique model that helps startups save on two big expenses—people and lab space—so founders can focus on the science without giving away too much equity too soon. We also take a detailed look into today’s biotech investment scene, the importance of solid clinical data, and how Curie guides startups from fundraising to hiring.
Lazar’s advice on pitching, building a team, and navigating the market is a must-hear for anyone raising funds in biotech.
Come and join us!